Trevi Therapeutics
TRVI
5,11 €
Share price
-7.60%
Change (1 day)
76.45%
Change (1 year)
Categories
EPS for Trevi Therapeutics (TRVI)
EPS in 2023 (TTM): -0,30 €
According to Trevi Therapeutics's latest financial reports the company's current EPS (TTM) is -0,28 €. In 2022 the company made an earnings per share (EPS) of -0,51 € an increase over its 2021 EPS that were of -1,37 €.
EPS history for Trevi Therapeutics from 2018 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -0,30 € | -41.87% |
| 2022 | -0,51 € | -62.67% |
| 2021 | -1,37 € | -17.29% |
| 2020 | -1,66 € | 18.17% |
| 2019 | -1,40 € | -46.21% |
| 2018 | -2,61 € |